{"DataElement":{"publicId":"6218967","version":"1","preferredName":"Cutaneous Melanoma AJCC Edition 8 Pathologic Regional Lymph Node N Category","preferredDefinition":"Extent of the regional lymph node involvement for skin melanoma based on clinical stage information combined with operative findings, and evidence obtained from pathology review when surgery is the first definitive therapy, using AJCC Ed. 8 criteria.","longName":"CMEL_AJC8_PTH_N_CAT","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"3357541","version":"1","preferredName":"Cutaneous Melanoma Pathologic N Stage","preferredDefinition":"A primary melanoma arising from atypical melanocytes in the skin. Precursor lesions include acquired and congenital melanocytic nevi, and dysplastic nevi. Several histologic variants have been recognized, including superficial spreading melanoma, acral lentiginous melanoma, nodular melanoma, and lentigo maligna melanoma._Caused by or altered by or manifesting disease or pathology._One criteria of the TMN staging system. N refers to the extent of lymph node involvement.","longName":"2431290v1.0:2428379v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"2431290","version":"1","preferredName":"Cutaneous Melanoma","preferredDefinition":"A malignant neoplasm derived from cells that are capable of forming melanin.","longName":"C3510","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cutaneous Melanoma","conceptCode":"C3510","definition":"A primary melanoma arising from atypical melanocytes in the skin.  Precursor lesions include acquired and congenital melanocytic nevi, and dysplastic nevi.  Several histologic variants have been recognized, including superficial spreading melanoma, acral lentiginous melanoma, nodular melanoma, and lentigo maligna melanoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"05DCF3BE-971D-3B79-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-18","endDate":null,"createdBy":"UMLLOADER_CAP","dateCreated":"2005-11-18","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2428379","version":"1","preferredName":"Pathologic N Stage","preferredDefinition":"Pathologic; caused by or altered by or manifesting disease or pathology.:One criteria of the TMN staging system. N refers to the extent of lymph node involvement.","longName":"C25610:C25580","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"N Category","conceptCode":"C25580","definition":"One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"053C2A34-084E-693F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-11","modifiedBy":"ONEDATA","dateModified":"2005-11-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6D76279-65A9-2CA8-E040-BB89AD434A54","latestVersionIndicator":"Yes","beginDate":"2012-01-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-18","modifiedBy":"TAYLORT","dateModified":"2018-04-09","changeDescription":"4/9/18 tt moved to NCI Standards Context. Created for CRF standard harmonization. Released per final community approval. mc 5/7/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6208763","version":"1","preferredName":"Cutaneous Melanoma American Joint Committee on Cancer Edition 8 Pathologic N Category","preferredDefinition":"A pathologic finding about one or more characteristics of cutaneous melanoma, following the rules of the TNM AJCC v8 classification system as they pertain to staging of regional lymph nodes. The TNM pathologic and clinical regional lymph nodes classifications of cutaneous melanoma are not the same. TNM pathologic findings are based on the microscopic examination of the regional lymph nodes, usually detected by lymphatic mapping and sentinel lymph node biopsy (clinically occult regional lymph node metastasis). (from AJCC 8th Ed.)_A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._One criteria of the TNM staging system. N refers to the extent of lymph node involvement._A grouping of items based on some commonality or by user defined characteristics.","longName":"6208763v1.0","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"N3c","valueDescription":"Cutaneous Melanoma pN3c TNM Finding v8","ValueMeaning":{"publicId":"6208806","version":"1","preferredName":"Cutaneous Melanoma pN3c TNM Finding v8","longName":"6208806","preferredDefinition":"Cutaneous melanoma with two or more clinically occult nodal metastases. Presence of in-transit, satellite, and/or microsatellite metastases: Yes. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cutaneous Melanoma pN3c TNM Finding v8","conceptCode":"C136966","definition":"Cutaneous melanoma with two or more clinically occult nodal metastases. Presence of in-transit, satellite, and/or microsatellite metastases: Yes. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6A237722-AD63-7440-E053-F662850A40B4","latestVersionIndicator":"Yes","beginDate":"2018-04-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-18","modifiedBy":"ONEDATA","dateModified":"2018-04-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6A237722-AD7C-7440-E053-F662850A40B4","beginDate":"2018-04-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-18","modifiedBy":"ONEDATA","dateModified":"2018-04-18","deletedIndicator":"No"},{"value":"N3a","valueDescription":"Cutaneous Melanoma pN3a TNM Finding v8","ValueMeaning":{"publicId":"6208808","version":"1","preferredName":"Cutaneous Melanoma pN3a TNM Finding v8","longName":"6208808","preferredDefinition":"Cutaneous melanoma with four or more clinically occult nodal metastasis (i.e., detected by sentinel lymph node biopsy). Presence of in-transit, satellite, and/or microsatellite metastases: No.  (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cutaneous Melanoma pN3a TNM Finding v8","conceptCode":"C136964","definition":"Cutaneous melanoma with four or more clinically occult nodal metastasis (i.e., detected by sentinel lymph node biopsy). Presence of in-transit, satellite, and/or microsatellite metastases: No.  (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6A237722-AD89-7440-E053-F662850A40B4","latestVersionIndicator":"Yes","beginDate":"2018-04-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-18","modifiedBy":"ONEDATA","dateModified":"2018-04-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6A237722-ADA2-7440-E053-F662850A40B4","beginDate":"2018-04-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-18","modifiedBy":"ONEDATA","dateModified":"2018-04-18","deletedIndicator":"No"},{"value":"N3","valueDescription":"Cutaneous Melanoma pN3 TNM Finding v8","ValueMeaning":{"publicId":"6208810","version":"1","preferredName":"Cutaneous Melanoma pN3 TNM Finding v8","longName":"6208810","preferredDefinition":"Cutaneous melanoma with four or more tumor-involved nodes or in-transit satellite, and/or microsatellite metastases with two or more tumor-involved nodes, or any number of matted nodes without or with in-transit, satellite, and/or microsatellite metastases. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cutaneous Melanoma pN3 TNM Finding v8","conceptCode":"C136963","definition":"Cutaneous melanoma with four or more tumor-involved nodes or in-transit satellite, and/or microsatellite metastases with two or more tumor-involved nodes, or any number of matted nodes without or with in-transit, satellite, and/or microsatellite metastases. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6A237722-ADAF-7440-E053-F662850A40B4","latestVersionIndicator":"Yes","beginDate":"2018-04-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-18","modifiedBy":"ONEDATA","dateModified":"2018-04-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6A237722-ADC8-7440-E053-F662850A40B4","beginDate":"2018-04-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-18","modifiedBy":"ONEDATA","dateModified":"2018-04-18","deletedIndicator":"No"},{"value":"N2c","valueDescription":"Cutaneous Melanoma pN2c TNM Finding v8","ValueMeaning":{"publicId":"6208812","version":"1","preferredName":"Cutaneous Melanoma pN2c TNM Finding v8","longName":"6208812","preferredDefinition":"Cutaneous melanoma with one clinically occult nodal metastasis. Presence of in-transit, satellite, and/or microsatellite metastases: Yes. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cutaneous Melanoma pN2c TNM Finding v8","conceptCode":"C136961","definition":"Cutaneous melanoma with one clinically occult nodal metastasis. Presence of in-transit, satellite, and/or microsatellite metastases: Yes. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6A237722-ADD5-7440-E053-F662850A40B4","latestVersionIndicator":"Yes","beginDate":"2018-04-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-18","modifiedBy":"ONEDATA","dateModified":"2018-04-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6A237722-ADEE-7440-E053-F662850A40B4","beginDate":"2018-04-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-18","modifiedBy":"ONEDATA","dateModified":"2018-04-18","deletedIndicator":"No"},{"value":"N3b","valueDescription":"Cutaneous Melanoma cN3b TNM Finding v8","ValueMeaning":{"publicId":"6183977","version":"1","preferredName":"Cutaneous Melanoma cN3b TNM Finding v8","longName":"6183977","preferredDefinition":"Cutaneous melanoma with four or more nodal metastases, at least one of which was clinically detected, or presence of any number of matted nodes. Presence of in-transit, satellite, and/or microsatellite metastases: No.  (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cutaneous Melanoma cN3b TNM Finding v8","conceptCode":"C136919","definition":"Cutaneous melanoma with four or more nodal metastases, at least one of which was clinically detected, or presence of any number of matted nodes. Presence of in-transit, satellite, and/or microsatellite metastases: No.  (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"69A92FFD-450D-42A2-E053-F662850A8F5B","latestVersionIndicator":"Yes","beginDate":"2018-04-12","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-12","modifiedBy":"ONEDATA","dateModified":"2018-04-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6BC54ACA-0B2A-537B-E053-F662850AB374","beginDate":"2018-05-09","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-09","modifiedBy":"ONEDATA","dateModified":"2018-05-09","deletedIndicator":"No"},{"value":"N2b","valueDescription":"Cutaneous Melanoma cN2b TNM Finding v8","ValueMeaning":{"publicId":"6183983","version":"1","preferredName":"Cutaneous Melanoma cN2b TNM Finding v8","longName":"6183983","preferredDefinition":"Cutaneous melanoma with two or three nodal metastases at least one of which was clinically detected. Presence of in-transit, satellite, and/or microsatellite metastases: No.  (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cutaneous Melanoma cN2b TNM Finding v8","conceptCode":"C136916","definition":"Cutaneous melanoma with two or three nodal metastases at least one of which was clinically detected. Presence of in-transit, satellite, and/or microsatellite metastases: No.  (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"69A92FFD-457F-42A2-E053-F662850A8F5B","latestVersionIndicator":"Yes","beginDate":"2018-04-12","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-12","modifiedBy":"ONEDATA","dateModified":"2018-04-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6BC54ACA-0B34-537B-E053-F662850AB374","beginDate":"2018-05-09","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-09","modifiedBy":"ONEDATA","dateModified":"2018-05-09","deletedIndicator":"No"},{"value":"N1b","valueDescription":"Cutaneous Melanoma cN1b TNM Finding v8","ValueMeaning":{"publicId":"6183989","version":"1","preferredName":"Cutaneous Melanoma cN1b TNM Finding v8","longName":"6183989","preferredDefinition":"Cutaneous melanoma with one clinically detected nodal metastasis. Presence of in-transit, satellite, and/or microsatellite metastases: No.  (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cutaneous Melanoma cN1b TNM Finding v8","conceptCode":"C136913","definition":"Cutaneous melanoma with one clinically detected nodal metastasis. Presence of in-transit, satellite, and/or microsatellite metastases: No.  (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"69A92FFD-45F1-42A2-E053-F662850A8F5B","latestVersionIndicator":"Yes","beginDate":"2018-04-12","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-12","modifiedBy":"ONEDATA","dateModified":"2018-04-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6BC54ACA-0B3E-537B-E053-F662850AB374","beginDate":"2018-05-09","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-09","modifiedBy":"ONEDATA","dateModified":"2018-05-09","deletedIndicator":"No"},{"value":"N2a","valueDescription":"Cutaneous Melanoma pN2a TNM Finding v8","ValueMeaning":{"publicId":"6208765","version":"1","preferredName":"Cutaneous Melanoma pN2a TNM Finding v8","longName":"6208765","preferredDefinition":"Cutaneous melanoma with two or three clinically occult nodal metastases (i.e., detected by sentinel lymph node biopsy). Presence of in-transit, satellite, and/or microsatellite metastases: No.  (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cutaneous Melanoma pN2a TNM Finding v8","conceptCode":"C136960","definition":"Cutaneous melanoma with two or three clinically occult nodal metastases (i.e., detected by sentinel lymph node biopsy). Presence of in-transit, satellite, and/or microsatellite metastases: No.  (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6A2360DE-8058-23E8-E053-F662850AB293","latestVersionIndicator":"Yes","beginDate":"2018-04-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-18","modifiedBy":"ONEDATA","dateModified":"2018-04-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6A2360DE-8071-23E8-E053-F662850AB293","beginDate":"2018-04-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-18","modifiedBy":"ONEDATA","dateModified":"2018-04-18","deletedIndicator":"No"},{"value":"N2","valueDescription":"Cutaneous Melanoma pN2 TNM Finding v8","ValueMeaning":{"publicId":"6208767","version":"1","preferredName":"Cutaneous Melanoma pN2 TNM Finding v8","longName":"6208767","preferredDefinition":"Cutaneous melanoma with two or three tumor-involved nodes or in-transit satellite, and/or microsatellite metastases with one tumor-involved node. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cutaneous Melanoma pN2 TNM Finding v8","conceptCode":"C136959","definition":"Cutaneous melanoma with two or three tumor-involved nodes or in-transit satellite, and/or microsatellite metastases with one tumor-involved node. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6A2360DE-807E-23E8-E053-F662850AB293","latestVersionIndicator":"Yes","beginDate":"2018-04-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-18","modifiedBy":"ONEDATA","dateModified":"2018-04-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6A2360DE-8097-23E8-E053-F662850AB293","beginDate":"2018-04-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-18","modifiedBy":"ONEDATA","dateModified":"2018-04-18","deletedIndicator":"No"},{"value":"N1c","valueDescription":"Cutaneous Melanoma pN1c TNM Finding v8","ValueMeaning":{"publicId":"6208769","version":"1","preferredName":"Cutaneous Melanoma pN1c TNM Finding v8","longName":"6208769","preferredDefinition":"Cutaneous melanoma with no regional lymph node disease. Presence of in-transit, satellite, and/or microsatellite metastases: Yes. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cutaneous Melanoma pN1c TNM Finding v8","conceptCode":"C136958","definition":"Cutaneous melanoma with no regional lymph node disease. Presence of in-transit, satellite, and/or microsatellite metastases: Yes. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6A2360DE-80A4-23E8-E053-F662850AB293","latestVersionIndicator":"Yes","beginDate":"2018-04-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-18","modifiedBy":"ONEDATA","dateModified":"2018-04-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6A2360DE-80BD-23E8-E053-F662850AB293","beginDate":"2018-04-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-18","modifiedBy":"ONEDATA","dateModified":"2018-04-18","deletedIndicator":"No"},{"value":"N1a","valueDescription":"Cutaneous Melanoma pN1a TNM Finding v8","ValueMeaning":{"publicId":"6208771","version":"1","preferredName":"Cutaneous Melanoma pN1a TNM Finding v8","longName":"6208771","preferredDefinition":"Cutaneous melanoma with one clinically occult nodal metastasis (i.e., detected by sentinel lymph node biopsy). Presence of in-transit, satellite, and/or microsatellite metastases: No.  (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cutaneous Melanoma pN1a TNM Finding v8","conceptCode":"C136957","definition":"Cutaneous melanoma with one clinically occult nodal metastasis (i.e., detected by sentinel lymph node biopsy). Presence of in-transit, satellite, and/or microsatellite metastases: No.  (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6A2360DE-80CA-23E8-E053-F662850AB293","latestVersionIndicator":"Yes","beginDate":"2018-04-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-18","modifiedBy":"ONEDATA","dateModified":"2018-04-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6A2360DE-80E3-23E8-E053-F662850AB293","beginDate":"2018-04-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-18","modifiedBy":"ONEDATA","dateModified":"2018-04-18","deletedIndicator":"No"},{"value":"N1","valueDescription":"Cutaneous Melanoma pN1 TNM Finding v8","ValueMeaning":{"publicId":"6208773","version":"1","preferredName":"Cutaneous Melanoma pN1 TNM Finding v8","longName":"6208773","preferredDefinition":"Cutaneous melanoma with one tumor-involved node or in-transit satellite, and/or microsatellite metastases with no tumor-involved nodes. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cutaneous Melanoma pN1 TNM Finding v8","conceptCode":"C136956","definition":"Cutaneous melanoma with one tumor-involved node or in-transit satellite, and/or microsatellite metastases with no tumor-involved nodes. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6A2360DE-80F0-23E8-E053-F662850AB293","latestVersionIndicator":"Yes","beginDate":"2018-04-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-18","modifiedBy":"ONEDATA","dateModified":"2018-04-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6A2360DE-8109-23E8-E053-F662850AB293","beginDate":"2018-04-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-18","modifiedBy":"ONEDATA","dateModified":"2018-04-18","deletedIndicator":"No"},{"value":"N0","valueDescription":"Cutaneous Melanoma pN0 TNM Finding v8","ValueMeaning":{"publicId":"6208775","version":"1","preferredName":"Cutaneous Melanoma pN0 TNM Finding v8","longName":"6208775","preferredDefinition":"Cutaneous melanoma without regional lymph node metastasis. Presence of in-transit, satellite, and/or microsatellite metastases: No.  (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cutaneous Melanoma pN0 TNM Finding v8","conceptCode":"C136955","definition":"Cutaneous melanoma without regional lymph node metastasis. Presence of in-transit, satellite, and/or microsatellite metastases: No.  (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6A2360DE-8116-23E8-E053-F662850AB293","latestVersionIndicator":"Yes","beginDate":"2018-04-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-18","modifiedBy":"ONEDATA","dateModified":"2018-04-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6A2360DE-812F-23E8-E053-F662850AB293","beginDate":"2018-04-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-18","modifiedBy":"ONEDATA","dateModified":"2018-04-18","deletedIndicator":"No"},{"value":"NX","valueDescription":"Cutaneous Melanoma pNX TNM Finding v8","ValueMeaning":{"publicId":"6208777","version":"1","preferredName":"Cutaneous Melanoma pNX TNM Finding v8","longName":"6208777","preferredDefinition":"Cutaneous melanoma in which the regional lymph nodes are not assessed (e.g., sentinel lymph node biopsy is not performed, regional lymph nodes were previously removed for another reason). Exception: pathological N category is not required for T1 melanomas, use cN. Presence of in-transit, satellite, and/or microsatellite metastases: No.  (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cutaneous Melanoma pNX TNM Finding v8","conceptCode":"C136954","definition":"Cutaneous melanoma in which the regional lymph nodes are not assessed (e.g., sentinel lymph node biopsy is not performed, regional lymph nodes were previously removed for another reason). Exception: pathological N category is not required for T1 melanomas, use cN. Presence of in-transit, satellite, and/or microsatellite metastases: No.  (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6A2360DE-813C-23E8-E053-F662850AB293","latestVersionIndicator":"Yes","beginDate":"2018-04-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-18","modifiedBy":"ONEDATA","dateModified":"2018-04-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6A2360DE-8155-23E8-E053-F662850AB293","beginDate":"2018-04-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-18","modifiedBy":"ONEDATA","dateModified":"2018-04-18","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6208762","version":"1","preferredName":"Cutaneous Melanoma Pathologic Regional Lymph Nodes TNM Finding v8 American Joint Committee on Cancer N Category Category","preferredDefinition":"A pathologic finding about one or more characteristics of cutaneous melanoma, following the rules of the TNM AJCC v8 classification system as they pertain to staging of regional lymph nodes. The TNM pathologic and clinical regional lymph nodes classifications of cutaneous melanoma are not the same. TNM pathologic findings are based on the microscopic examination of the regional lymph nodes, usually detected by lymphatic mapping and sentinel lymph node biopsy (clinically occult regional lymph node metastasis). (from AJCC 8th Ed.):A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:One criteria of the TNM staging system. N refers to the extent of lymph node involvement.:A grouping of items based on some commonality or by user defined characteristics.","longName":"C136953:C39315:C25580:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cutaneous Melanoma Pathologic Regional Lymph Nodes TNM Finding v8","conceptCode":"C136953","definition":"A pathologic finding about one or more characteristics of cutaneous melanoma, following the rules of the TNM AJCC v8 classification system as they pertain to staging of regional lymph nodes. The TNM pathologic and clinical regional lymph nodes classifications of cutaneous melanoma are not the same. TNM pathologic findings are based on the microscopic examination of the regional lymph nodes, usually detected by lymphatic mapping and sentinel lymph node biopsy (clinically occult regional lymph node metastasis). (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"N Category","conceptCode":"C25580","definition":"One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6A2360DE-802B-23E8-E053-F662850AB293","latestVersionIndicator":"Yes","beginDate":"2018-04-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-18","modifiedBy":"ONEDATA","dateModified":"2018-04-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"6A2360DE-803C-23E8-E053-F662850AB293","latestVersionIndicator":"Yes","beginDate":"2018-04-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-18","modifiedBy":"TAYLORT","dateModified":"2018-05-09","changeDescription":"5/9/18 tt added 3 PVs. 4/18/18 tt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"6005920","version":"1","longName":"AJCC Edition 8","context":"NCI Standards"},{"publicId":"10000090","version":"1","longName":"Cutaneous Melanoma","context":"NCI Standards"}]},{"publicId":"6545315","version":"1","longName":"SI Workshop Query Categories","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6545446","version":"1","longName":"Pathologic Diagnosis/Stage/Grade","context":"NCIP"}]},{"publicId":"6601273","version":"1","longName":"CPTAC (Clinical Proteomic Tumor Analysis Consortium)","context":"OCCPR","ClassificationSchemeItems":[{"publicId":"10000348","version":"1","longName":"Melanoma","context":"OCCPR"},{"publicId":"7634324","version":"1","longName":"CM Baseline","context":"OCCPR"}]}],"AlternateNames":[{"name":"OCCPR","type":"USED_BY","context":"OCCPR"}],"ReferenceDocuments":[{"name":"Pathologic N category","type":"Preferred Question Text","description":"Pathologic N category","url":null,"context":"NCI Standards"},{"name":"CPTAC-BSLN-1","type":"Alternate Question Text","description":"Pathologic Staging: Regional Lymph Nodes (pN)","url":null,"context":"OCCPR"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"6A335A76-6D51-69A0-E053-F662850A60B3","latestVersionIndicator":"Yes","beginDate":"2018-04-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-19","modifiedBy":"KNABLEJ","dateModified":"2021-07-26","changeDescription":"4/19/18 tt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}